Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News Daily News

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Caitlin E. Cox

January 03, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Features

Top News in Imaging: 2018

Caitlin E. Cox

December 28, 2018

News Daily News

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

Todd Neale

November 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Daily News

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Yael L. Maxwell

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

Advertisement

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Top News in Imaging: 2018

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

TCTMD’s Top 10 Most Popular Stories for November 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content